BridgeMD
Compares treatment options for Vascular Access Site Occlusion
Official title DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention
ClinicalTrials.gov ID: NCT05490238
What this study is testing
- What it's testing
- The use of the distal radial artery has recently emerged as a promising alternative access route to further reduce the risk of radial artery occlusion (RAO) and has been endorsed by recent International Consensus documents. The feasibility of a distal radial access (DRA) for coronary angiography and/or PCI has been demonstrated in several observational clinical registries and small-sized randomized clinical trials.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years.
- Patients presenting with CCS or ACS, including unstable angina or NSTEMI.
- Patients planned for PCI of complex coronary lesions, such as CTO, left main coronary artery disease, heavily calcified lesions, complex...
- Patients able to provide written informed consent.
You likely can't join if
- Patients with acute ST-segment elevation myocardial infarction.
- Patients with cardiogenic shock.
- Patients on chronic hemodialysis.
- Patients with contraindications to TRA, such as occlusive upper arm peripheral artery disease, or known anatomic variants prohibiting TRA on both...
- Patients with medical conditions that may cause non-compliance with the study protocol and/or may confound the data interpretation.
- Patients unable to provide written informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Arlon, Belgium
- Brussels, Belgium
- Charleroi, Belgium
- La Louvière, Belgium
- Hamburg, Germany
- Pátrai, Greece
- Milan, Italy
- Basel, Basel, Switzerland
- Geneva, Canton of Geneva, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Arlon, Belgium; Brussels, Belgium; Charleroi, Belgium; La Louvière, Belgium; Hamburg, Germany; Pátrai, Greece and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.